Kim, J.; Byun, H.K.; Kim, T.H.; Kim, S.I.; Kim, B.K.; Kim, S.U.; Park, J.Y.; Kim, D.Y.; Seong, J.
Liver-Directed Concurrent Chemoradiotherapy versus Sorafenib in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis. Cancers 2022, 14, 2396.
https://doi.org/10.3390/cancers14102396
AMA Style
Kim J, Byun HK, Kim TH, Kim SI, Kim BK, Kim SU, Park JY, Kim DY, Seong J.
Liver-Directed Concurrent Chemoradiotherapy versus Sorafenib in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis. Cancers. 2022; 14(10):2396.
https://doi.org/10.3390/cancers14102396
Chicago/Turabian Style
Kim, Jina, Hwa Kyung Byun, Tae Hyung Kim, Sun Il Kim, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Do Young Kim, and Jinsil Seong.
2022. "Liver-Directed Concurrent Chemoradiotherapy versus Sorafenib in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis" Cancers 14, no. 10: 2396.
https://doi.org/10.3390/cancers14102396
APA Style
Kim, J., Byun, H. K., Kim, T. H., Kim, S. I., Kim, B. K., Kim, S. U., Park, J. Y., Kim, D. Y., & Seong, J.
(2022). Liver-Directed Concurrent Chemoradiotherapy versus Sorafenib in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis. Cancers, 14(10), 2396.
https://doi.org/10.3390/cancers14102396